ArticleBMJ open2020

Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.

Rachel E Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.